Previous close | N/A |
Open | 6.15 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 6.15 - 6.15 |
52-week range | 6.15 - 6.15 |
Volume | 500 |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.34 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Neal Walker became the CEO of Aclaris Therapeutics, Inc. (NASDAQ:ACRS) in 2012, and we think it's a good time to look...
The big shareholder groups in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) have power over the company. Institutions often...